Justification for Atherosclerosis Regression Treatment [JART Extension Study]
Phase of Trial: Phase III
Latest Information Update: 17 May 2016
At a glance
- Drugs Rosuvastatin (Primary) ; Pravastatin
- Indications Atherosclerosis; Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms JART
- 29 Aug 2012 Results of an analysis of the extension study (n=118) presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.
- 16 Nov 2011 Results published in Circulation Journal.
- 31 Aug 2011 Actual patient number (n=295) reported in an abstract presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History